Insurance coverage varies across New York, so it is worth checking with both your provider and insurer before starting
Is it okay if tirzepatide gets warm
Experimental protocols were reviewed and approved by the Institutional and Animal Care Use Committee (IACUC) of Baylor College of Medicine
Results of the phase 3b TOGETHER-PsA trial showed ixekizumab administered together with tirzepatide in comorbid overweight or obese adults with psoriatic arthritis showed clinically meaningful improvement of psoriatic disease, physical function, weight reduction, & quality-of-life, with no new safety concerns Read the full results in Arthritis & Rheumatology Ixekizumab with Tirzepatide Improves Psoriatic Arthritis in Overweight Adults Results of the phase 3b TOGETHER-PsA trial showed ixekizumab administered together with tirzepatide in comorbid overweight or obese adults with psoriatic arthritis showed clinically meaningful improvement of psoriatic disease, physical function, weight reduction, & quality-of-life, with no new safety concerns Read the full results in Arthritis & Rheumatology To view or add a comment, sign in More Relevant Posts Super interesting results of Together PsA and the idea of combining anti-cytokine approaches with a modulator of the GLP1 axis
It depends on the pathway
However, this can be associated with a drop in blood calcium levels, and thus, close monitoring is required
